Fresenius Kabi’s Cancer Drug Subsidiary Pleads Guilty to Destroying Records

By Sam | March 1, 2021

Fresenius Kabi Oncology (FKO) has agreed to plead guilty to hiding and destroying records prior to a 2013 FDA inspection and will hand over $50 million in fines and forfeiture, the U.S. Department of Justice revealed.
Source: Drug GMP Report

Posted in Drug GMP Report